argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
853.82
-18.76 (-2.15%)
Jul 31, 2026, 4:00 PM EDT - Market closed
argenx SE Market Cap
argenx SE has a market cap or net worth of $53.6 billion as of July 31, 2026. Its market cap has increased by 47.29% in one year.
Market Cap
53.60B
Enterprise Value
48.42B
1-Year Change
47.29%
Ranking
Category
Stock Price
$853.82
ChartMarket Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $53.60B, an increase of 8,572.45%. That is a compound annual growth rate of 62.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 53.40B | 4.03% |
| Dec 31, 2025 | 51.33B | 39.57% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 120.54B |
| Regeneron Pharmaceuticals | 76.00B |
| Revolution Medicines | 40.20B |
| BeOne Medicines AG | 35.01B |
| Royalty Pharma | 33.96B |
| Alnylam Pharmaceuticals | 27.24B |
| Roivant Sciences | 24.68B |
| Incyte | 24.40B |